Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Avenzo Therapeutics Appoints Connie Wedel As Chief Human Resources Officer

PRIVATEAug 24, 2026about 3 hours ago

Position

Chief Human Resources Officer

Company

Avenzo Therapeutics

Connie Wedel
San DiegoBiotechnologyTherapeuticsPharmaceutical

Description

Avenzo Therapeutics has announced the appointment of Connie Wedel to the position of Chief Human Resources Officer. This strategic move aims to enhance the company's workforce management and organizational effectiveness.

Company Information

Company

Avenzo Therapeutics

Location

9171 TOWNE CENTRE DRIVE, SUITE 380

San Diego, California, United States

About

Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients. The company’s lead drug candidate, AVZO-021, is a novel, highly potent and selective inhibitor of CDK2, a key enzyme involved in cell cycle regulation. AVZO-021 is being studied in a Phase 1 study in the U.S. for the treatment of advanced solid tumors.

Don't miss Avenzo Therapeutics's next move

Get an email the moment Avenzo Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Athena
Senior decision-maker at this company
••••••••@••••••••

See Athena's verified email →

Nicole
Senior decision-maker at this company
••••••••@••••••••

See Nicole's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Avenzo Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Avenzo Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.